In mice, RANKL seems to worsen insulin sensitivity, while the decoy receptor OPG, which physiologically antagonizes the activity of RANKL on osteoclast precursors, is able to delay the onset of hyperglycemia in diabetic animals. Here, INS is linked to Hyperglycemia.